2022 VC spending couldn't compete with 2021. Here's how Philly companies fared
The pandemic, a possible recession and global issues are to blame for a less-booming — but still impressive — year, per PitchBook-NCVA researchers. Meanwhile, life science companies in the Greater Philadelphia region reined in the most capital in Q4.
Source: technical.ly